Letter to the Editor
Page 33
Letter to the Editor
Efficacy of Duloxetine and Agomelatine Does Not Exceed That of Other Antidepressants in Patients With Autistic Disorder: Preliminary Results in 3 Patients
February 24, 2011
The authors of this case report share results from a 10-week trial of duloxetine (40 mg daily) and agomelatine (25 mg daily) in 3 patients with autism.